IL6 and cancer: The activation of several miRNAs (e.g., miR-21 and miR-181-b1) by the IL-6/STAT3 axis has been proposed to maintain the transformed state by increasing NF-κB activity through suppression of PTEN and CYLD tumor suppressors in diverse cell lines, thus forming a positive feedback loop linking inflammation to cancer [126].